Organization

Altoona Center for Clinical Research, Altoona Arthritis and Osteoporosis Center, Duncansville, United States of America

3 abstracts

Abstract
A PHASE 2 TRIAL OF PERESOLIMAB FOR ADULTS WITH RHEUMATOID ARTHRITIS
Org: Eli Lilly and Company, San Diego Clinical Services, San Diego State University Department of Biology, San Diego, CA, United States of America, Csolnoky Ferenc Hospital,
Abstract
A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING SECUKINUMAB 300 MG AND 150 MG AT WEEK 52 IN PATIENTS WITH ANKYLOSING SPONDYLITIS WHO DID NOT ACHIEVE INACTIVE DISEASE DURING AN INITIAL 16 WEEKS OF OPEN-LABEL TREATMENT WITH SECUKINUMAB 150 MG
Org: Oregon Health & Science University, Rheumatology, Portland, United States of America, Altoona Center for Clinical Research, Altoona Arthritis and Osteoporosis Center, Duncansville, United States of America, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Rheumatology, Cleveland, United States of America, University of Utah School of Medicine and Salt Lake City Veterans Affairs Medical Center, Rheumatology, Salt Lake City, United States of America, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Rheumatology, Seattle, United States of America,
Abstract
B CELL DEPLETION IN SUBJECTS WITH CONTROLLED SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AFTER INTRAVENOUS OR SUBCUTANEOUS ADMINISTRATION OF SBI-087
Org: Metroplex Clinical Research Center, Dallas, United States, Miami Research Associates, Miami, Altoona Center for Clinical Research, Altoona Arthritis and Osteoporosis Center, Duncansville, United States of America, Pfizer, Collegeville, United States,